Clinical Trials

Does Surfactant Therapy Help Infants With Severe Bronchiolitis?
Research & Development Does Surfactant Therapy Help Infants With Severe Bronchiolitis?

Understanding the complex interplay between viral infections and lung function has long been a cornerstone of pediatric research aimed at reducing infant mortality during peak winter respiratory seasons. Bronchiolitis stands as the primary reason for hospital admissions among infants under one year

Can Robots Make Brain Angiography Safer and Faster?
Research & Development Can Robots Make Brain Angiography Safer and Faster?

The historical landscape of neurovascular intervention has long been defined by the physical endurance of surgeons who navigate intricate cranial pathways while draped in heavy protective lead. Cerebral angiography remains the gold standard for diagnosing life-threatening conditions like brain

Lab-Grown Esophagus Offers New Hope for Pediatric Patients
Research & Development Lab-Grown Esophagus Offers New Hope for Pediatric Patients

The field of pediatric surgery is currently witnessing a paradigm shift, moving away from purely mechanical repairs toward the biological reconstruction of complex organs. For children born with long-gap esophageal atresia, the challenge has always been the physical impossibility of connecting two

Can Korean Biotech Redefine Next-Gen Cancer Treatments?
Research & Development Can Korean Biotech Redefine Next-Gen Cancer Treatments?

The 2026 American Association for Cancer Research annual meeting in San Diego stands as a definitive proving ground where South Korean biotechnology firms must transition from theoretical promise to clinical validation. Unlike later-stage conferences such as ASCO or ESMO, the AACR provides a unique

Why Is Cancer Trial Access So Unequal in Black Communities?
Research & Development Why Is Cancer Trial Access So Unequal in Black Communities?

For a patient navigating the harrowing landscape of a cancer diagnosis, the difference between survival and a terminal prognosis often hinges on the proximity of their residence to cutting-edge medical research facilities. Despite significant breakthroughs in precision oncology and immunotherapy, a

Henlius Challenges Pfizer in PD-L1 Lung Cancer Drug Race
Research & Development Henlius Challenges Pfizer in PD-L1 Lung Cancer Drug Race

The pharmaceutical landscape is currently witnessing a high-stakes confrontation as Shanghai Henlius Biotech maneuvers to intercept Pfizer’s dominance in the next generation of lung cancer therapy. At the heart of this struggle is the development of antibody-drug conjugates (ADCs) targeting PD-L1,

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later